For the Latest Information on COVID-19 in the USA, see:
Covid-19 Healthcare Coalition - https://c19hcc.org/
Centers for Disease Control & Prevention - https://www.cdc.gov/
Health and Human Services - https://www.hhs.gov/
Sections and Organization
I. Supporting Documentation Cover Letter
II. Main Manuscript Components:
I. Supporting Documentation Cover Letter
This document facilitates blinded review and production of galley proofs should the submission be accepted. All eleven (11) items below should be contained in the Supporting Documentation Cover Letter.
Article category guidelines
Follow guidance for developing each component below. Many manuscripts are rejected due to formatting issues. For additional resources available to aid authors in improving article quality, please see:
Include a full title of up to 200 characters
Enter all qualifying author names in the order each should appear on the manuscript including the following details:
The submitting author will be designated as the “corresponding author” in the submission system. Corresponding authors act as BHTY's primary contact and the only author able to view or change the manuscript while it is under editorial review.
The corresponding author role may be transferred to another coauthor with the written approval of all authors. Transferring the corresponding author role also transfers access to the manuscript submission. The corresponding author will be listed as such upon publication.
3a. Corresponding author contact details
Please provide full contact details for the corresponding author including email, mailing address, and telephone number(s).
3b. Submission Category selection
The corresponding author will select the BHTY Submission Category below for the manuscript submission:
Manuscripts are exclusively submitted to BHTY, with the understanding they have not been published elsewhere, in any form, and will not be submitted elsewhere, unless declined by BHTY.
BHTY endeavors to follow, the ICMJE recommendations for scholarly work in medical journals, as it aspires to adhere to the highest standards of scholarly publication practices. Details may be obtained here. Below you will find the "Role of Authors and Contributors" as outlined by ICMJE. Should you wish for a more detailed explanation, please click here. All authors must meet all four criteria below.
BHTY urges researchers to consider researcher contributions and authorship criteria in multi-region collaborations in effort to promote greater equity and transparency in research collaborations. Researchers should follow the recommendations set out in the Global Code of Conduct for Research in Resource-Poor Settings when designing, executing and reporting their research and provide a disclosure statement in their manuscript regarding the global ethics code.
Consortia Authors, a collective of authors, or large multi-author group, can be listed as a consortium or "group name." Individual authors can be listed on the main author and consortium lists. All authors within a consortium must be listed at the end of the paper. As per the ICMJE, "when submitting a manuscript authored by a group, the corresponding author should specify the group name if one exists, and clearly identify the group members who can take credit and responsibility for the work as authors."
Non-Author Contributors who do not meet the criteria above can be listed in the Acknowledgments section of your manuscript. See the International Committee of Medical Journal Editors (ICMJE) guidelines for "Non-Author Contributors" here. Obtaining funding, collecting of data, or overall supervision of a research group does not qualify authorship. Authors are required to include a statement of responsibility in the manuscript that specifies the contribution of every author.
ORCID IDs should be included for all authors.
BHTY expects all authors to review, discuss, and agree to their individual contributions and roles.
5. Popular scientific summary
An optional new feature is availble to authors for articles in BHTY featuring a short paragraph (maximum 75 words) of bullet points to help the reader understand what the paper adds to the topic (what’s new), and what the implications of the paper are (e.g., what action needs to be taken). Choose words and phrases carefully.
Those who contributed to the work but do not meet authorship criteria should be listed in Acknowledgments with a description of their role. Authors are responsible for ensuring those named in Acknowledgments agree to be included.
7. Previous manuscript submission
If a manuscripts was submitted to another journal and declined, the author should disclose why, and what attempts have been made to revise the manuscript, for resubmission. Authors are responsible for all statements made in the article and references cited.
8. Disclosure of Financial and Non-Financial Relationships and Activities
Authors are responsible for disclosing financial and non-financial relationships and activities that might bias the interpretation of results.
Relationships and activities may include any financial interests, direct or indirect, that might raise questions regarding bias in the your work, conclusions, implications or perspectives stated – including relevant commercial or other sources of funding for each individual author.
Public trust in the scientific process and credibility of published articles hinges in part, on the transparency and trust publishers and authors are able to insure from collecting and reporting research, to writing research manuscripts, peer review, editing and publication of work. Professional judgements must not be influenced by financial gain. Purposeful failure to disclose relationships and activities is a form of misconduct. Authors must disclose all as per journal requirements and forms. The ICMJE has developed a Disclosure Form to facilitate and standardize authors’ disclosures. Authors are required to submit this form when a manuscript is submitted. Upload it on the BHTY journal submission portal when you upload your manuscript.
It is the role of the corresponding author to ensure this is adhered to.
9. Editorial suitability and Author Confirmation(s)
Please address the following questions:
10. Redundant or Duplicate Publication
According to COPE, a redundant publication is a “work, or sections of that work, that is published more than once.” If redundant or duplicate publication is attempted or occurs without notification to BHTY, the journal will follow the editorial action contained in the COPE Flowchart for Redundant Publication.
Authors should alert the editor if the work includes subject matter about which a previous paper has been published. Referred work should be referenced in the new paper. Copies of materials, including papers in press, should be submitted with your manuscript submission to assist the editor in determining how to handle the issue.
We ask you provide up to five (5) article keywords relating to your manuscript and subject matter.
This is important for SEO indexing for search engines and can heighten searchability of articles and improve relevancy for readers. Keywords should be included in titles, subheadings and at the beginning and end of work.
Use Google Adwords to find keywords that will provide the most visibility for your work.
12. Funding Statement
This section should describe sources of funding that have supported the work. Please include relevant grant numbers and the URL of any funder's web site. Please also include this sentence: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Otherwise, describe the role of your sponsors or funders, and amend the aforementioned sentence as needed.
II. Main Manuscript File Submission (faciltates double blind review):
1. Title page
Include a full title of up to 200 characters without author names or titles, to ensure double blind peer review.
Your original research manuscript submission MUST contain an abstract. The Abstract comes after the title page in the manuscript file. The journal requires structured abstracts. The abstract should be 250-400 words. Please see CONSORT or PRISMA style abstract formats to determine which to use for your paper.
The abstract must be structured with headings (Objective, Design, Setting, Participants, Interventions, Main outcome measures, Results, Conclusions). For meta-analyses headings are typically: Objective, Design, Results, and Conclusion.
Provide trial registration number(s) for clinical randomized controlled trials.
Trials must be registered in a public trials registry that i a primary register of the WHO International Clincial Trials Registry Platform (ICTRP), at or before enrolling the first patient and registrations must have 24 -item trial registratio dataset.
The Introduction should present a broad context for the manuscript. Think of readers who are not experts that may read your article. Include a brief review of key literature. If there are relevant issues pro and con in the field, mention them so a non-expert can understand. The Introduction should end with a statement of the overall purpose of the experiment(s) and a commentary on whether it was achieved.
This section should clearly describe your study rationale. It should end with a statement of the specific study hypothesis and/or study objectives.
Methods should provide enough detail for reproduction of the findings. Protocols for new methods should be included. Well-established methodological procedures may simply be referenced. A full description of the methods should be included within the manuscript.
Methods should also include a section with descriptions of any statistical methods used. The description should conform to the ICMJE Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication, published in the J Pharmacol Pharmacother. 2010 Jan-Jun; 1(1): 42–58., and available at the following link here. It reads as follows:
Submit detailed protocols for newer or less established methods. Well-established protocols may simply be referenced. Protocol documents for clinical trials, observational studies, and other non-laboratory investigations may be uploaded as supporting information.
We recommend you explore laboratory protocols in protocols.io, where protocols can be assigned their own persistent digital object identifiers (DOIs).
To include a link to a protocol in your article:
This allows editors and reviewers to consult your protocol when evaluating the manuscript. Any referenced protocol(s) will automatically be made public when your article is published.
Provide an interpretation of results with recommendations for future research.
For clinical trials, provide the trial identification number(s) and name(s) (e.g., trial registration number, protocol number or acronym).
6a. Human and Animal Subjects
BHTY endorses appropriate reporting guidelines when writing a health research manuscript. The most commonly required reporting guidelines may be found on the EQUATOR Network , which also gives general information on how to choose the correct guideline and why guidelines are important.
BHTY follows the guidelines of the International Committee of Medical Journal Editors.
When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), and/or in accordance with the Helsinki Declaration (revised in 2013). Authors must explain rationale for their approach and demonstrate the institutional review body explicitly approved any doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment as to whether the conduct of the research was appropriate. Authors must remember to add the trial registration number to the end of the abstract.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects, observing privacy rights of human subjects. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent requires an identifiable patient is shown the manuscript to be published. Informed consent should be obtained if there is any doubt that anonymity can be maintained. If identifying characteristics are de-identified, authors should provide assurance that such changes do not distort scientific meaning.
For manuscripts reporting experiments on animals, the corresponding author must confirm that all experiments were performed in accordance with relevant guidelines and regulations. The manuscript must include a statement identifying the institutional and/or licensing committee approving the experiments, including any relevant details.
The Results section should include all primary and secondary outcome measures analyzed. The section may be divided into subsections, each with a concise subheading. Tables and figures central to the study should be included in the main paper. The Results section should be written in past tense.
For smaller data sets and certain data types, authors may provide their data within their manuscript or in Supporting Information files accompanying the manuscript. Authors should attempt to maximize the accessibility and reusability of data by selecting file formats where data can be easily and efficiently extracted. An example is spreadsheets or flat files in lieu of PDFs for tabulated data.
Ensure the methodology has been accurately described for statistical analysis. Include details and access to original data to verify results. Provide confidence levels, and define terms and symbols. Include software used. In comparative studies, power calculations are usually required. In research manuscripts, requiring complex statistics, the advice of an expert statistician should be sought at the design/implementation stage of the study. It is appropriate to include statisticians as co-authors. Should you have further questions, please contact the managing editor.
BHTY strongly urges authors to make all data underlying the findings described in their manuscript fully available without restriction. Authors can include relevant software code and data in the peer review process by uploading it to BHTY’s Code Ocean computational reproducibility workflow; and strengthen the validity, attribution, and trust-based reputation of their work with BHTY’s ARTiFACTS.ai service option, a purpose built blockchain-enabled platform for academic and scientific research and development.
The Discussion should be tightly argued. Start with a summary of the main findings. Include paragraphs on the generalizability, clinical relevance, strengths, and limitations of your study. You may also want to add the following:
All available works can be cited in the reference list and must be formatted in the Vancouver style. MANUSCRIPTS WILL BE REJECTED IF NOT FORMATTED PROPERLY. For details visit https://www.nlm.nih.gov/bsd/uniform_requirements.html
Acceptable sources for references include:
Make sure the parts of the manuscript are in the correct order before ordering the citations.
Two examples of Vancouver style for the most commonly cited references are shown below. Note: bold type shows what must be added to the citation if available. Do not use bold type in your reference list.
If you have the DOI:
Oliver M, Teruel MA, Molina JP, Romero-Ayuso D, González P. Ambient intelligence environment for home cognitive telerehabilitation. Sensors (Basel) 2018;18:3671-4. DOI: https://doi.org/10.3390/s18113671
If you have the URL:
Xixi L, Rai A, Ganapathy K. Designing cost-effective telemedicine camps for underprivileged individuals in less developed countries: a decomposed affordance-effectivity framework. J Assoc Inf Syst 2020;25:9-12. Available from: https://aisel.aisnet.org/jais/vol21/iss5/3 [cited 9 July 2021].
Authors can submit essential supporting files and multimedia files along with their manuscripts. All supporting information will be subject to peer review. All file types can be submitted. Supporting information files are published exactly as provided, and are not copyedited.
Supporting information captions
List supporting information captions at the end of the manuscript file and not in a separate file. The file number and name are required in a caption. We recommend including a one-line title. You can include a legend, but it is not required.
Figure preparation files and integrity
BHTY acknowledges authors may manipulate images for purposes of clarity. Manipulation for purposes of deception or fraud is ethical misconduct and will be dealt with accordingly. Images may not be enhanced, obscured, moved, removed, or inserted. Please follow the CSE's guidelines for more information: http://www.councilscienceeditors.org/resource-library/editorial-policies/white-paper-on-publication-ethics/3-4-digital-images-and-misconduct
Cite tables in ascending numeric order upon first appearance in the manuscript file.
Place each table in your manuscript file directly after the paragraph in which it is first cited (read order). Do not submit your tables in separate files.
Tables require a label (e.g., “Table 1”) and brief descriptive title to be placed above the table. Place legends, footnotes, and other text below the table.
Multimedia and 3D Models
BHTY publishes multimedia and 3D models embedded in the HTML and PDF versions of articles. These will be displayed in line with article text, as are with figures.
Multimedia and 3D models are accepted when needed to show findings that 1) are critical to argue article conclusions and 2) can't be satisfactorily presented in text, table, or figure. The editors will determine if this medium is used appropriately.
Multimedia and 3D models must be numbered independently of figures and tables, and cited at the relevant point in the manuscript text, e.g., “Movie 1”, and “Model 1”.
A title should be part of the legend and not incorporated in the multimedia or 3D model itself.
A legend must be included in the manuscript document after the reference list and not included in the video or 3D model itself. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information. If videos are not in real time and the time is not displayed in the video, the period represented must be stated in the legend. Rather than stating “See text,” legends should be more specific; for example, “See Results”.
Size and Format
Video and 3D models should be sized to convey essential scientific information. 3D models must be in U3D format.
Video file size limit is 25 MB. If the video file is larger, please supply it via WeTransfer or Dropbox. Upon publication of the article, large video files can be placed on a separate server or repository (Figshare) or similar, whereby a link to the video file will be included in the article abstract.
Please be sure to optimize videos for PC, tablet, and smartphone viewing.
For each video, please submit a preview image, or poster frame, that best illustrates the main focus.
Should you have additional questions as to Figures, Tables, and Multimedia, please contact the managing editor or publisher.
BHTY accepts video submissions to compliment an author's written work. Videos can demonstrate simulations, experimental demos, or "interviews" with authors/researchers. Authors should submit a jpeg representing the video and/or transcript of audio. Video format may be MP4. Length: 5-7 minutes maximum.
Should you have additional questions as to Figures, Tables, and Multimedia, please contact the managing editor or publisher.
An Open Access Online Journal Published by Partners in Digital Health.
BHTY is published under a Creative Commons Attribution-NonCommercial 4.0 International License.
BHTY will also publish content in other products such as license editions of BHTY and grant republication sublicense in journals around the world.
Owned and managed by: Partners in Digital Health (PDH).
OUR PARTNERS and MEMBERSHIPS